[1]
Saadia Ilyas et al. 2024. ORAL PGE2 IN DUCTUS-DEPENDENT CONGENITAL HEART DEFECTS: CROSS-SECTIONAL EVIDENCE FROM 52 CASES. Journal of Population Therapeutics and Clinical Pharmacology. 31, 3 (Mar. 2024), ORAL PGE2 IN DUCTUS-DEPENDENT CONGENITAL HEART DEFECTS: CROSS-SECTIONAL EVIDENCE FROM 52 CASES. DOI:https://doi.org/10.53555/jptcp.v31i3.7558.